Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
Associated filings
- 28 Dec 23 424B3 Prospectus supplement
- 28 Dec 23 EFFECT Notice of effectiveness
- 20 Dec 23 S-4/A Registration of securities issued in business combination transactions (amended)
-
8 Dec 23 S-4/A Registration of securities issued in business combination transactions (amended)
- 17 Nov 23 S-4/A Registration of securities issued in business combination transactions (amended)
- 3 Nov 23 S-4/A Registration of securities issued in business combination transactions (amended)
- 12 Oct 23 S-4/A Registration of securities issued in business combination transactions (amended)
- 18 Sep 23 S-4/A Registration of securities issued in business combination transactions (amended)
- 31 Jul 23 S-4 Registration of securities issued in business combination transactions
TRUG similar filings
Filing view
External links
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the inclusion in this Registration Statement on Form S-4 (Amendment No. 5) of our report dated May 30, 2023, except for Note 7 which is dates July 31, 2023 with respect to the audited financial statements of Deep Medicine Acquisition Corp. for the years ended March 31, 2023 and 2022. Our report contains an explanatory paragraph regarding the Company’s ability to continue as a going concern.
We also consent to the references to us under the heading “Experts” in such Registration Statement.
/s/ MaloneBailey, LLP
www.malonebailey.com
Houston, Texas
December 8, 2023